))
The Bob Harrington Show is a podcast series of thoughtful interviews and discussions on topics at the core of cardiology and the practice of medicine.
…
continue reading
Oracle Life Sciences Vice President of Global Innovation, Kathy Vandebelt, interviews industry experts and leaders on pressing topics in the Life Sciences industry.
…
continue reading
Clinical research and clinical trial management form the backbone of drug and device approvals worldwide. Learn from the leading industry experts to build and advance your clinical research career. You'll hear from sponsors, clinical research organizations, and clinical trial sites around the globe. This show is for all current and aspiring clinical research professionals including clinical research associates (CRA), clinical operations managers, study managers, biostatisticians, medical doc ...
…
continue reading
1
Cardiology 2024 Highlights and Predictions for 2025
36:09
36:09
Play later
Play later
Lists
Like
Liked
36:09
Drs Harrington and Gibson review their picks for the top cardiology trials of 2024 and look ahead to 2025, particularly what health topics may be prioritized by the new administration. This podcast is intended for healthcare professionals only. To read a transcript or to comment https://www.medscape.com/author/bob-harrington Beta-Blockers after Myo…
…
continue reading
1
Does ST-Elevation MI Need a Rebrand to ‘Occlusion MI’?
20:16
20:16
Play later
Play later
Lists
Like
Liked
20:16
A review paper prompted a discussion among cardiologists Bob Harrington, Manesh Patel, and Michael Gibson on whether the ST-segment elevation myocardial infarction paradigm needs an update. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington From ST-Seg…
…
continue reading
1
Cardiovascular Disease 2050: No, GLP-1s Won't Save the Day
14:51
14:51
Play later
Play later
Lists
Like
Liked
14:51
Cardiologists Bob Harrington and Dhruv Kazi discuss the projected burden of cardiovascular disease in 2050, why it's not sustainable, and what can be done to prevent it. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington INCLUDE URLS and full titles fo…
…
continue reading
1
From Fact to Fiction: Medical Journalist–Turned-Author
20:41
20:41
Play later
Play later
Lists
Like
Liked
20:41
Dr Bob Harrington interviews journalist Shelley Wood about her new book, "The Leap Year Gene of Kit McKinley," her creative process, and the difference between medical journalism and writing fiction. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington T…
…
continue reading
1
Private Equity in Medicine: Cardiology in the Crosshairs
25:53
25:53
Play later
Play later
Lists
Like
Liked
25:53
Medical practices are increasingly being acquired by private equity. Bob Harrington discusses why and what the ramifications are with the authors and editorialist of a research paper on the private equity landscape in cardiology vs other specialties. This podcast is intended for healthcare professionals only. To read a transcript or to comment, vis…
…
continue reading
1
Cardiology Clinical Trials with Dr. Gregg Stone
1:09:14
1:09:14
Play later
Play later
Lists
Like
Liked
1:09:14
To learn more about this important field of cardiovascular clinical research, I invited Dr. Gregg Stone on the podcast. Dr. Stone is an Interventional Cardiologist and Director of Academic Affairs for the Mount Sinai Heart Health System and Professor of Medicine (Cardiology) and Professor of Population Health Sciences and Policy at the Icahn School…
…
continue reading
In this episode, you will learn about what type of insurance (if any) is needed to conduct a clinical trial. We also discuss different insurance provisions, choosing the right insurance partner, regulatory requirements that dictate insurance and much more. Dan is a seasoned insurance professional with 10+ years of underwriting and broking experienc…
…
continue reading
1
Food Is Not Medicine but Maybe It's Healthcare
21:29
21:29
Play later
Play later
Lists
Like
Liked
21:29
Bob Harrington and Mitch Elkind discuss "food is medicine" initiatives and the challenges associated with conducting clinical trials. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington Health Care by Food Initiative https://healthcarexfood.org/ 2021 Di…
…
continue reading
Bob Harrington interviews fellow cardiologist Mike McConnell about his new book Fight Heart Disease Like Cancer and the need to model heart disease prevention and treatment after cancer. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington Fight Heart Di…
…
continue reading
1
Correlation Is Not Causation, Wink, Is Not Good Enough for Observational Research
23:56
23:56
Play later
Play later
Lists
Like
Liked
23:56
Cardiology researchers Bob Harrington and Bobby Yeh discuss how to do better observational research and the controversial notion of making causal inferences from such data. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington Academic Cardiology and Soci…
…
continue reading
1
Diabetes Clinical Trials with Dr. Stayce Beck
17:26
17:26
Play later
Play later
Lists
Like
Liked
17:26
To learn more about clinical trials in diabetes, I invited Dr. Stayce Beck, Global Vice President of Clinical Affairs at Dexcom Inc. on the podcast. Dr. Beck currently oversees clinical operations, clinical strategy and science, biometrics and human factors at Dexcom Inc, a leading manufacturer of continuous glucose monitors (CGMs) Prior to joining…
…
continue reading
1
Publish or Perish and the Incentive for Quantity over Quality Research Papers
20:53
20:53
Play later
Play later
Lists
Like
Liked
20:53
Bob Harrington, Erin Michos, and Brahmajee Nallamothu discuss how the publish or perish culture can lead to sloppy research and the need for alternative models to measure success in academic medicine. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington …
…
continue reading
1
Hot Topics Cardiologists Love to Hate: MOC and AI
13:49
13:49
Play later
Play later
Lists
Like
Liked
13:49
Bob Harrington and Mike Gibson discuss two of the hottest topics in cardiology and medicine for 2023: a proposed alternative to the maintenance of certification process, and artificial intelligence. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington Ca…
…
continue reading
For this year's review, Bob Harrington and Mike Gibson revisit the major cardiology conferences -- from ACC in New Orleans to AHA in Philly. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit: https://www.medscape.com/author/bob-harrington ACC 2023 Top Trials - Bempedoic Acid Cuts CV Events in Stat…
…
continue reading
1
Access to Novel Medical Products with Dr. Alison Bateman-House
1:13:43
1:13:43
Play later
Play later
Lists
Like
Liked
1:13:43
Providing patients access to novel medical products can be challenging to navigate for sponsors and trial participants alike. To learn more about expanded access, compassionate use, Right to Try laws, I invited Dr. Alison Bateman-House, PhD, MPH, MA, an Assistant Professor in the Division of Medical Ethics at NYU Gross…
…
continue reading
1
SCD in Athletes: Lessons From High-Profile Cases
18:19
18:19
Play later
Play later
Lists
Like
Liked
18:19
Bob Harrington and Manesh Patel discuss sudden cardiac death in athletes and the importance of the chain of survival. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington COVID and the Athlete's Heart https://www.medscape.com/viewarticle/945282 Outcomes …
…
continue reading
1
Ep. 43: Running regulatory and clinical operations in an AI world
41:27
41:27
Play later
Play later
Lists
Like
Liked
41:27
Artificially intelligent tools are revolutionizing nearly every stage of the drug discovery process, offering substantial potential to reshape the speed and economics of the industry. As the drug discovery and preclinical stages speed up and potentially produce more drugs to test in the clinical trial phase, how do clinical researchers prepare and …
…
continue reading
1
Clinical Research as a Profession with Erika Stevens
1:28:35
1:28:35
Play later
Play later
Lists
Like
Liked
1:28:35
Unlike an electrical engineer or a plumber, clinical research roles are not explicitly defined or categorized as such, in government employment databases. There are no certification or degree requirements to work as a clinical research professional either. To explore the topic of clinical research as a profession, I invited Erike Stevens on the pod…
…
continue reading
1
Community Engagement in Clinical Trials with Chris Komelasky
1:20:33
1:20:33
Play later
Play later
Lists
Like
Liked
1:20:33
To learn about community engagement in clinical trials, what it means, recent regulations and guidance documents, I invited Chris Komelasky, CEO and Co-founder of SiteBridge Research, on the podcast. SiteBridge Research is an Integrated Research Organization (IRO). Chris and his team help connect physicians and their patients to clinical trials and…
…
continue reading
1
Ep. 42: Creating drugs at the speed of AI
27:39
27:39
Play later
Play later
Lists
Like
Liked
27:39
Artificial intelligence (AI) is one of the most discussed technologies across all industries. Life science professionals working in the pharmaceutical industry strive to improve people’s lives tackling incredibly complex diseases. Drug development is often perceived as slow. As the pharma industry looks to improve the drug development process AI pr…
…
continue reading
1
From Physician to Patient to Reinventing Medicine
25:52
25:52
Play later
Play later
Lists
Like
Liked
25:52
Bob Harrington interviews Jag Singh about the COVID journey that led to his book, Future Care: Sensors, Artificial Intelligence, and the Reinvention of Medicine. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit: https://www.medscape.com/author/bob-harrington Future Care: Sensors, Artificial Intel…
…
continue reading
1
Ep. 41: CancerX: Reducing incidence, burden, and disparities in cancer care
50:11
50:11
Play later
Play later
Lists
Like
Liked
50:11
Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. President Biden has reignited the Cancer Moonshot initiative and set a new national goal: “if we work together, we can cut the death rate from cancer by at least 50% over the next 25 years and improve the experience of people and their families living wit…
…
continue reading
1
Ep. 40: CancerX: Breaking down the barriers to digital innovation use in oncology
30:52
30:52
Play later
Play later
Lists
Like
Liked
30:52
The US cancer death rate has fallen by 33% since 1991 with an estimated 3.8 million deaths averted. This is attributed to “good progress” improvements in cancer treatment, decreases in smoking, and increases in early detection. A recent rise in advanced cancer cases reported is believed to be an outcome of the COVID-19 pandemic which delayed screen…
…
continue reading
1
Community health system-based research with JoAnne Levy
1:32:40
1:32:40
Play later
Play later
Lists
Like
Liked
1:32:40
Community health system-based research continues to become an important focus area for pharmaceutical and medical device sponsors given the recent FDA guidance on diversity in clinical trials. Our guest for this episode is JoAnne Levy, Vice President at Mercy Research, a part of Mercyhealth. Mercy Research is one of the largest fully integrated, co…
…
continue reading
1
Ep. 39: Recruiting and retaining experienced principal investigators
39:55
39:55
Play later
Play later
Lists
Like
Liked
39:55
The success or failure of clinical trials is dependent in large part on the engagement of the principal investigator (PI). PIs play an important role in trial selection, site activation, and study execution. This includes but is not limited to, the development and implementation of a strategy to maximize enrollment, optimize data quality, and ensur…
…
continue reading
1
Postmarket Surveillance Studies with David Rutledge
1:21:02
1:21:02
Play later
Play later
Lists
Like
Liked
1:21:02
In this episode, we’re going to talk about Postmarket Surveillance Studies. In light of the EU Medical Device Regulation (MDR), medical device manufacturers are required to implement a Postmarket Surveillance (PMS) plan, which in turn may require them to conduct Postmarket Surveillance Studies. The importance of such studies has grown in recent yea…
…
continue reading
1
AI and Machine Learning in Healthcare for the Clueless: No Coding Required
22:24
22:24
Play later
Play later
Lists
Like
Liked
22:24
Robert Harrington, MD and Jenine John, a cardiologist and machine learning research fellow discuss what you need to know about AI and ML in healthcare and where to find some helpful resources. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit: https://www.medscape.com/author/bob-harrington 'One Br…
…
continue reading
1
Human-centered design role in clinical trials with Bruce Hellman and Ben James
1:21:21
1:21:21
Play later
Play later
Lists
Like
Liked
1:21:21
In this episode, we explore the role of design in clinical trials. Most clinical research professionals are so focused on protocol design, data collection, and analysis that it’s easy to overlook the importance of well-designed technology that supports clinical trials. One such technology product is electronic Patient Reported Outcomes or ePROs. eP…
…
continue reading
